Advertisement

The Scientist

» drug development and immunology

Most Recent

image: Rethinking Lymphatic Development

Rethinking Lymphatic Development

By | August 1, 2015

Four studies identify alternative origins for cells of the developing lymphatic system, challenging the long-standing view that they all come from veins.

0 Comments

image: The Human Touch

The Human Touch

By | August 1, 2015

Can mice with humanlike tissues better model drug effects in people?

0 Comments

image: The Spleen Collectors

The Spleen Collectors

By | August 1, 2015

Donated organs are helping researchers map out the immune system in humans.

0 Comments

image: Yun “Nancy” Huang: Eager for Epigenetics

Yun “Nancy” Huang: Eager for Epigenetics

By | August 1, 2015

Assistant Professor, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston. Age: 35

0 Comments

image: Teva Buys Allergan Generics for $40.5 Billion

Teva Buys Allergan Generics for $40.5 Billion

By | July 27, 2015

Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal. 

0 Comments

image: EMA Green Lights Malaria Vax

EMA Green Lights Malaria Vax

By | July 27, 2015

The European Medicines Agency endorses the first-ever malaria vaccine for use in children 6 weeks to 17 months old.

0 Comments

image: NK Cell Diversity and Viral Risk

NK Cell Diversity and Viral Risk

By | July 22, 2015

A small study links the diversity of a person’s natural killer cell repertoire to risk of HIV infection following exposure to the virus.

0 Comments

image: HHS Partners on Ebola Drug

HHS Partners on Ebola Drug

By | July 22, 2015

The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.

0 Comments

image: Novel Hantavirus Infection Method

Novel Hantavirus Infection Method

By | July 3, 2015

Researchers find that the potentially deadly virus uses cholesterol to gain access to cells.

0 Comments

image: MERS Help on the Horizon?

MERS Help on the Horizon?

By | July 1, 2015

New research finds that a treatment for Middle East respiratory syndrome can prevent and treat the disease in mice, while an experimental vaccine moves into human testing.

0 Comments

Advertisement

Popular Now

  1. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  2. Most Earth-like Planet Found
  3. Ancient Viruses as Gene Therapy Vectors
  4. Judge Decides on GM Rice Retraction
Advertisement
Advertisement